The significance of antiphospholipid antibodies in pregnant women with chronic hypertension

American Journal of Perinatology

Volumn 21, Issue 5, 2004, Pages 275-279

  Zeeman, Gerda G ^a,b   Alexander, James M ^b   McIntire, Donald D ^b   Leveno, Kenneth J ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antiphospholipid antibody; Chronic hypertension; Preeclampsia

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY SCREENING; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; RISK FACTORS;

EID: 3142654213     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-829870     Document Type: Article

References (11)

1. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985;313:1322-1326
2. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992;80:614-620
3. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161:369-373
4. Lima F, Khamashta MA, Buchanan NM, Kerslake S, Hunt BJ, Hughes GR. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996;14:131-136
5. Antiphospholipid syndrome. ACOG Educational Bulletin no. 244. Washington, DC: ACOG; February 1999
6. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-763
7. Branch DW, Porter TF, Rittenhouse L, et al. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001;184:825-832
8. Pattison NS, Chamley LW, Birdsall M, Zanderigo AM, Liddell HS, McDougall J. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 2000;183:1008-1012
9. Rai R, Cohen H, Dave M, Refan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997;314:253-257
10. Harris EN. The second international anticardiolipin standardization workshop: the Kingston antiphospholipid antibody study (KAPS) group. Am J Clin Pathol 1990;94: 476-484
11. Parry S, Macones GA, Roth NW, Desperito TJ, Marzullo A, Morgan MA. Antiphospholipid antibodies in chronic hypertension: the value of screening during pregnancy. Am J Perinatol 1998;15:527-531